Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6

Blood

Volumn 95, Issue 11, 2000, Pages 3341-3348

  Potter, Mark D ^b   Buijs, Arjan ^b   Kreider, Brent ^b   Van Rompaey, Luc ^b   Grosveld, Gerard C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; MITOGEN ACTIVATED PROTEIN KINASE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0342646965     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3341.011k44_3341_3348     Document Type: Article

References (41)

1. Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta. 1998; 1377:F1-F11.
2. Ghysdael J, Boureux A. The Ets family of transcriptional regulators. In: Yaniv M, Ghysdael J, eds. Oncogenes as Transcriptional Regulators. Vol 1. Basel, Switzerland: Birkhauser Verlag; 1997:22.
3. Sharrocks AD, Brown AL, Ling Y, Yates PR. The ETS-domain transcription factor family. Int J Biochem Cell Biol. 1997;29:1371.
4. Graves BJ, Petersen JM. Specificity within the ETS family of transcription factors. Adv Cancer Res. 1998;75:1.
5. Janknecht R, Nordheim A. Gene regulation by Ets proteins. Biochim Biophys Acta. 1993;1155: 346.
6. Crepieux P, Coll J, Stehelin D. The ETS family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit Rev Oncog. 1994;5:615.
7. Wasylyk B, Hagman J, Gutierrez-Hartmann A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci. 1998;23:213.
8. Bassuk AG, Leiden JM. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv Immuno. 1997;64:65.
9. Leprince D, Gegonne A, Coll J, et al. A putative second cell-derived oncogene of the avian leukaemia retrovirus E27. Nature. 1983;306:395.
10. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, fli1, closely linked to c-ets1. Genes Dev. 1991;5:908.
11. Paul R, Scheutze S, Kozak SL. The SFPI-1 proviral integration site of Friend erythroleukemia encodes the Ets-related transcription factor PU.1. J Virol. 1991;65:464.
12. Golub T, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG. The Tel gene and human leukemia. Biochim Biophys Acta. 1996; 1288:M7.
13. Adams M, Dbunick M, Kerlavage A, et al. Sequence identification of 2375 human brain genes. Nature. 1992;355:632.
14. Smith R, Wiese B, Wojzynski M, Davison D, Worley K. BCM search launcher - an integrated interface to molecular biology data base search and analysis services available on the World Wide Web. Genet Res. 1996;6:454.
15. Thompson J, Higgins D, Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673.
16. Pearson W, Lipman D. Improved tools for biological sequence analysis. Proc Natl Acad Sci U S A. 1990;85:2444.
17. Fornerod M, Boer J, van Baal S, et al. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements. Oncogene. 1995;10:1739.
18. Buijs A, Molijn A, Davis N, et al. The MN1-TEL fusion protein, resulting from the t(12;22) (p13; q11) in myeloid leukemia, is a chimeric transcription factor that transforms NIH3T3 cells. Mol Cell Biol. Submitted.
19. Hollenbach A, Sublett J, McPherson C, Grosveld G. The pax3-fkhr oncoprotein is unresponsive to the pax3-associated repressor hdaxx. EMBO J. 1999;18:3702.
20. Savant BS, Cleveland DW. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a >20S degradation complex. Genes Dev. 1992;6: 1927.
21. Laudet V, Hanni C, Stehelin D, Duterque-Coquillaud M. Molecular phylogeny of the ETS gene family. Oncogene. 1999;18:1351.
22. Jousset C, Carron C, Boureux A, et al. A domain of tel conserved in a subset of ets proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J. 1997;16:69.
23. Poirel H, Oury C, Carron C, et al. The tel gene products: nuclear phosphoproteins with DNA binding properties. Oncogene. 1997;14:349.
24. Smith J, Ostrowski M. TREF-a tel related Ets factor. Submitted.
25. Baens M, Peeters P, Guo C, Aerssens J, Marynen P. Genomic organization of tet the human Ets-variant gene 6. Genet Res. 1996;6: 404.
26. Rebay I, Rubin G. YAN functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway. Cell. 1995;81:857.
27. Lim F, Kraut N, Frampton J, Graf T. DNA binding by c-Ets1, but not v-Ets, is repressed by an intramolecular mechanism. EMBO J. 1992;11:643.
28. Wasylyk C, Kerckaert J, Wasylyk B. A novel modulator domain of Ets transcription factors. Genes Dev. 1992;6:965.
29. Basuyaux J, Ferreira E, Stehelin D, Buttice G. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner. J Biol Chem. 1997;272: 27,188.
30. Carrere S, Verger A, Flourens A, Stehelin D, Duterque-Coquillaud M. Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains. Oncogene. 1998;16:3271.
31. Kwiatkowski B, Bastian S, Bauer T, Tsai S, Zielinska-Kwiatkowska A, Hickstein D. The Ets family member Tel binds to the Fli1 oncoprotein and inhibits its transcriptional activity. J Biol Chem. 1998;273:17,525.
32. Bassuk A, Leiden J. A direct physical association between ETS and AP1 transcription factors in normal human T cells. Immunity. 1995;3:223.
33. Kim W-Y, Sieweke M, Ogawa E, et al. Mutual activation of ETS1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 1999;18:1609.
34. Mao S, Frank R, Zhang J, Miyazaki Y, Nimer S. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol Cell Biol. 1999;19:3635.
35. Wang L, Kuo F, Fujiwara Y, Gilliland DG, Golub T, Orkin S. Yolk sac angiogenic defect and intra-ambryonic apoptosis in mice lacking the Ets-related factor Tel. EMBO J. 1997;16:4374.
36. Wang L, Swat W, Fujiwara Y, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998;12:2392.
37. Strausberg R. Cancer Genome Anatomy Project. Available at: http://www.ncbi.nlm.nih.gov/ncicap/. Accessed June 10, 1999.
38. Hromas R, Klemsz M. The ETS oncogene family in development, proliferation and neoplasia. Int J Hematol. 1994;59:257.
39. Moreau-Gachelin F, Mattei M-G, Tambourin P, Tavitian A. The putative oncogene spi. murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene. 1989;4:1449.
40. Shore P, Whitmarsh A, Bhaskaran R, Davis R, Waltho J, Sharrocks A. Determinants of DNA-binding specificity of ETS-domain transcription factors. Mol Cell Biol. 1996;16:3338.
41. Lopez R, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J. TEL is a sequence-specific transcriptional repressor. J Biol Chem. 1999;274: 30,132.